Pathology

Uzm. Dr. Elif Kardelen Çağdaş

Doctor and researcher Afyonkarahisar Devlet Hastanesi Afyonkarahisar
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionAfyonkarahisar Devlet Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications19 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-5358-3444ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://afyonkarahisardh.saglik.gov.tr/TR-1328499/tibbi-patoloji-doktorlarimiz.html#elif-kardelen-cagdassaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

19 publications

  1. Primary Acantholytic Squamous Cell Carcinoma of the Breast With Basal-Like Immunophenotype and Low Proliferation: A Case Report and Literature Review

    International Journal of Surgical Pathology, 2026

    DOI 10.1177/10668969261461531 PMID 42554839 Source: ORCID

  2. Integrating machine learning with histopathological, immunohistochemical, and PET parameters in the study of invasive breast carcinoma, no special type

    Cancer Imaging, 2026

    DOI 10.1186/s40644-026-01075-z PMID 42351264 Open-access full textSource: ORCID

  3. From pathways to prediction: a comparative machine learning framework for prostate cancer survival

    Bioinformatics Advances, 2026

    DOI 10.1093/bioadv/vbag093 PMID 42004869 1 citation (Europe PMC) Open-access full textSource: ORCID

  4. Cecal leiomyoma mimicking a right adnexal mass: A rare diagnostic challenge

    Journal of Clinical Sciences, 2026

    DOI 10.4103/jcls.jcls_120_25 Open-access full textSource: ORCID

  5. Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study

    Annals of nuclear medicine, 2026

    DOI 10.1007/s12149-026-02193-1 PMID 41849022 Source: ORCID

  6. Pathway-level somatic mutation burden reflects diffuse genomic accumulation rather than selective transcriptional disruption in ovarian serous carcinoma: Evidence from bulk, spatial, and multi-region genomic analyses

    Gynecologic Oncology, 2026

    DOI 10.1016/j.ygyno.2026.04.010 PMID 42034009 Open-access full textSource: ORCID

  7. Methylation-Expression Discordance Reveals Immune Pathway-Specific Epigenetic Dysregulation in IDH-Wildtype Glioblastoma

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9306530/v1 Open-access full textSource: OpenAlex

  8. Concordance Between WHO 2022 and ICC 2022 Classifications of Myeloid Neoplasms: A Single-Center Clinicopathological and Molecular Analysis

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9569530/v1 Open-access full textSource: OpenAlex

  9. Clonal hematopoiesis of indeterminate potential and outcomes of CD19-directed chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a systematic review and meta-analysis

    2026

    DOI 10.17605/osf.io/zhvrt Open-access full textSource: OpenAlex

  10. Glioblastoma spatial transcriptomics

    Zenodo (CERN European Organization for Nuclear Research), 2026

    DOI 10.5281/zenodo.21249430 Open-access full textSource: OpenAlex

View all 19 publications